Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BBG | Ann: Removal from Official List - Close of trading 26/04/2018 | 26/04/18 | 0 | 1.6K | |||
|
|||||||
BBG | Ann: Implementation of Scheme of Arrangement | 24/04/18 | 0 | 1.1K | |||
|
|||||||
BBG | Ann: Suspension from Official Quotation - COT 9/4/2018 | 09/04/18 | 0 | 893 | |||
|
|||||||
BBG | Ann: Scheme of Arrangement is Legally Effective | 09/04/18 | 0 | 1.9K | |||
|
|||||||
BBG | Ann: Federal Court of Australia Approves Scheme of Arrangement | 06/04/18 | 0 | 1.0K | |||
|
|||||||
BBG | Ann: Scheme Meeting Results - Improved Offer From Boardriders | 28/03/18 | 6 | 6.0K | |||
|
See All Discussions